Browse files

Dataset

Evaluation of capture and amplicon-based targeted sequencing methods on formalin-fixed tumours

Dataset ID	Technology	Samples
EGAD00001006879	Illumina MiSeq	56

Dataset Description

Three capture (Agilent’s SureSelectXT HS, Illumina’s Nextera Rapid Capture Custom, and New England Biolabs’ Next Direct Custom) and one amplicon-based (Qiagen’s Human Breast Cancer Panel) targeted sequencing methods on 6-8 paired blood and FFPE from the Malaysian Breast Cancer Cohort.

Data Use Conditions

PUB US PS IS

See further information on Data Use Conditions

Label	Code	Version
publication required	DUO:0000019	2021-02-23
user specific restriction	DUO:0000026	2021-02-23
project specific restriction	DUO:0000027	2021-02-23
institution specific restriction	DUO:0000028	2021-02-23
non-commercial use only	DUO:0000046	2021-02-23

Who controls access to this dataset

For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. If you need to request access to this data set, please contact:

DAC Panel Evaluation
Contact person: Professor Soo-Hwang Teo
Email: genetics [at] cancerresearch [dot] my
More details: EGAC00001001914

Downloads

You don't have access to the download section.

This dataset is featured in 1 study

Studies are experimental investigations of a particular phenomenon. e.g. case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients. Click on one of the Study IDs below to find out more.

Study ID	Study Title	Study Type
EGAS00001004965	Evaluation of capture and amplicon-based targeted sequencing methods on formalin-fixed tumours	Other

EGA Beacon